Surgenex® is committed to turning innovative scientific research into industry leading human cellular and tissue-based products.
The patented Excellion® process is used to produce the highest quality allograft tissues using tightly controlled surgical procedures.
Surgenex® prides itself on exceeding regulatory safety standards through rigorous quality processes and third-party serological testing.
With unprecedented service and care for providers and their patients our staff is dedicated to providing the very best at a competitive price.
Dehydrated, terminally irradiated membranes available in multiple configurations and sizesLearn More
Orthobiologic allografts processed to preserve the native biomechanical structure of the tissueLearn More
Decellularized and processed to preserve the biological properties that promote revascularization and repairLearn More
Custom analytical development for characterization and lot release testingLearn More
All tissue goes through extensive donor screening and is solely procured by FDA registered tissue banks.
Through tightly controlled surgical procedures the tissue is cleaned, processed, and stored to maximize its therapeutic benefits.
Each product is carefully inspected by our Quality Assurance Team and stored in a controlled and monitored environment to ensure quality and longevity.
Harnessing the power of the amniotic membrane's natural properties to provide a protective covering in a variety of therapeutic applications.
Harnessing the power of the amniotic membrane's natural properties to provide a protective covering for use in ophthalmic applications.Learn More
Mr. Bullock has over a decade of experience in the medical industry working for PSS World Medical and McKesson Medical-Surgical. He founded Surgenex in 2014 with the first allograft product launch occurring in July 2015. His previous experience is with creating fast-growth companies with low overhead and operational excellence. He has led the rapid expansion of Surgenex and its product offerings. Mr. Bullock has an International Master's degree in Business from CW POST in New York, the European Business School in London, and the American University of Paris in Paris. Mr. Bullock's undergraduate degree is in Business Management from Missouri State University.
Mr. Robinson has nearly two decades of Private Equity and Venture Capital experience in CFO and Controller roles including previous experience working with tissue banks. Mr. Robinson has worked closely with many entrepreneurs through rapid growth cycles and M&A transaction. Mr. Robinson has a BS of Accounting and Business Management, and an MBA degree. He is also a Certified Valuation Analyst (CVA), and a Certified Merger and Acquisition Advisor (CM&AA).
Mr. Diaz has over 30 years of sales, commercial operations and executive leadership experience in the biologics and medical device industries. He has worked at both public and private companies including Matria Healthcare, MiMedx and BioIQ. Through his career, Mr. Diaz has led negotiations on multi-year, multimillion-dollar contracts with GPOs and IDNs and many Fortune 500 companies. He obtained a Master of International Management from Schiller International University, a Bachelor of Science in International Affairs from Florida State University and is a Six Sigma Green Belt. He lived in Europe for 16 years and speaks German.